• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nondopaminergic neurons in Parkinson's disease.

作者信息

Hirsch E C, Orieux G, Muriel M-P, Francois C, Feger J

机构信息

Inserm U289, Department of Experimental Neurology and Therapeutics, Hôpital de la Salpêtrière, Paris, France.

出版信息

Adv Neurol. 2003;91:29-37.

PMID:12449099
Abstract
摘要

相似文献

1
Nondopaminergic neurons in Parkinson's disease.帕金森病中的非多巴胺能神经元。
Adv Neurol. 2003;91:29-37.
2
Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?帕金森病的生物化学：脑血清素缺乏是特发性帕金森病的一个特征吗？
Adv Neurol. 2003;91:39-49.
3
Functional neuroanatomy of the basal ganglia in Parkinson's disease.帕金森病中基底神经节的功能神经解剖学
Adv Neurol. 2003;91:9-18.
4
Potential nondopaminergic drugs for Parkinson's disease.帕金森病的潜在非多巴胺能药物。
Adv Neurol. 2003;91:273-91.
5
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.帕金森病治疗的新见解：左旋多巴诱导的运动障碍是否可控。
Adv Neurol. 2003;91:51-64.
6
The functional anatomy of noradrenergic neurons in Parkinson's disease.帕金森病中去甲肾上腺素能神经元的功能解剖学
Funct Neurol. 1999 Apr-Jun;14(2):97-109.
7
Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.在帕金森病相关脑病理学分期病例中，迈斯纳神经丛和奥尔巴赫神经丛中的胃α-突触核蛋白免疫反应性包涵体。
Neurosci Lett. 2006 Mar 20;396(1):67-72. doi: 10.1016/j.neulet.2005.11.012. Epub 2005 Dec 5.
8
Overview of the extranigral aspects of Parkinson disease.帕金森病黑质外方面概述
Arch Neurol. 2009 Feb;66(2):167-72. doi: 10.1001/archneurol.2008.561.
9
Parkinson's disease is a neuropsychiatric disorder.帕金森病是一种神经精神障碍。
Adv Neurol. 2003;91:365-70.
10
Dopamine agonists, sleep disorders, and driving in Parkinson's disease.
Adv Neurol. 2003;91:343-9.

引用本文的文献

1
Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review.帕金森病信号通路、分子机制及潜在治疗策略：综述
Int J Mol Sci. 2025 Jul 3;26(13):6416. doi: 10.3390/ijms26136416.
2
Therapeutic Effect of Human Adipocyte-derived Stem Cell-derived Exosomes on a Transgenic Mouse Model of Parkinson's Disease.人脂肪来源干细胞衍生的外泌体对帕金森病转基因小鼠模型的治疗作用。
In Vivo. 2023 Sep-Oct;37(5):2028-2038. doi: 10.21873/invivo.13300.
3
Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions.
帕金森病中的信号通路：分子机制与治疗干预。
Signal Transduct Target Ther. 2023 Feb 21;8(1):73. doi: 10.1038/s41392-023-01353-3.
4
Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice.基质金属蛋白酶-8抑制剂改善LRRK2 G2019S帕金森病模型小鼠的炎症反应和行为缺陷。
Biomol Ther (Seoul). 2021 Sep 1;29(5):483-491. doi: 10.4062/biomolther.2020.181.
5
Effect of spironolactone on pain responses in mice.螺内酯对小鼠疼痛反应的影响。
EXCLI J. 2010 Feb 25;9:46-57. eCollection 2010.
6
Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice.慢性轻度应激暴露对MPTP/丙磺舒诱导的小鼠神经毒性特定脑区运动、非运动损伤及神经化学变量的影响。
PLoS One. 2016 Jan 14;11(1):e0146671. doi: 10.1371/journal.pone.0146671. eCollection 2016.
7
Social behavioral changes in MPTP-treated monkey model of Parkinson's disease.帕金森病MPTP处理猴模型中的社会行为变化
Front Behav Neurosci. 2015 Feb 26;9:42. doi: 10.3389/fnbeh.2015.00042. eCollection 2015.
8
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.尼古丁、可替宁及其代谢产物作为帕金森病潜在治疗药物的有益作用。
Front Aging Neurosci. 2015 Jan 9;6:340. doi: 10.3389/fnagi.2014.00340. eCollection 2014.
9
Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.早期帕金森病和多系统萎缩中5-羟色胺转运体的可用性
ISRN Neurol. 2014 Feb 3;2014:345132. doi: 10.1155/2014/345132. eCollection 2014.
10
SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias.在早期帕金森病中，SERT 与 DAT 的比值与运动障碍的发展无关。
EJNMMI Res. 2013 Jun 5;3(1):44. doi: 10.1186/2191-219X-3-44.